Words of wisdom. Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

Published

Other Article

Full Text

Duke Authors

Cited Authors

  • Inman, BA

Published Date

  • July 2013

Published In

Volume / Issue

  • 64 / 1

Start / End Page

  • 171 - 172

PubMed ID

  • 23746323

Pubmed Central ID

  • 23746323

Electronic International Standard Serial Number (EISSN)

  • 1873-7560

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2013.04.027

Language

  • eng

Conference Location

  • Switzerland